 | • レポートコード：D0GIR-00981 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗体薬物複合体（ADC）薬物の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗体薬物複合体（ADC）薬物の種類別市場規模（免疫学技術、免疫原技術、シアトル遺伝学技術、その他）、用途別市場規模（バイオテクノロジー企業、専門癌センター、バイオ医薬品企業、学術研究機関、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Oxford Bio Therapeutics、Roche Holding AG、Bayer HealthCare、Synthon、Concortis Bio therapeutics、Progenics Pharmaceuticals、Heidelberg Pharma、Pfizer、Millennium Pharmaceuticals、Seattle Genetics、Immunomedics、ImmunoGen、Mersana Therapeutics、Genmab、Agensys、Celldex Therapeutics、Astellas Pharma/Agensys、Sanofi、Genentech、AbbVie Inc、Amgen、Novartis、Eli Lilly ・地域別グローバル市場分析 2015年-2020年 ・抗体薬物複合体（ADC）薬物の北米市場（アメリカ、カナダ、メキシコ） ・抗体薬物複合体（ADC）薬物のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗体薬物複合体（ADC）薬物のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗体薬物複合体（ADC）薬物の南米市場（ブラジル、アルゼンチン） ・抗体薬物複合体（ADC）薬物の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫学技術、免疫原技術、シアトル遺伝学技術、その他 ・用途別分析：バイオテクノロジー企業、専門癌センター、バイオ医薬品企業、学術研究機関、病院、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Antibody Drug Conjugate (ADC) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Antibody Drug Conjugate (ADC) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Antibody Drug Conjugate (ADC) Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antibody Drug Conjugate (ADC) Drug market has been segmented into:
Mmunomedics Technology
Immunogen Technology
Seattle Genetics Technology
Others
By Application, Antibody Drug Conjugate (ADC) Drug has been segmented into:
Biotechnology Companies
Specialized Cancer Centers
Biopharmaceutical Companies
Academic Research Institutes
Hospitals
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibody Drug Conjugate (ADC) Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibody Drug Conjugate (ADC) Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibody Drug Conjugate (ADC) Drug market.
The report offers in-depth assessment of the growth and other aspects of the Antibody Drug Conjugate (ADC) Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Antibody Drug Conjugate (ADC) Drug Market Share Analysis
Antibody Drug Conjugate (ADC) Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antibody Drug Conjugate (ADC) Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibody Drug Conjugate (ADC) Drug sales, revenue and market share for each player covered in this report.
The major players covered in Antibody Drug Conjugate (ADC) Drug are:
Oxford Bio Therapeutics
Roche Holding AG
Bayer HealthCare
Synthon
Concortis Bio therapeutics
Progenics Pharmaceuticals
Heidelberg Pharma
Pfizer
Millennium Pharmaceuticals
Seattle Genetics
Immunomedics
ImmunoGen
Mersana Therapeutics
Genmab
Agensys
Celldex Therapeutics
Astellas Pharma/Agensys
Sanofi
Genentech
AbbVie Inc
Amgen
Novartis
Eli Lilly
Among other players domestic and global, Antibody Drug Conjugate (ADC) Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Antibody Drug Conjugate (ADC) Drug Market Overview
1.1 Product Overview and Scope of Antibody Drug Conjugate (ADC) Drug
1.2 Classification of Antibody Drug Conjugate (ADC) Drug by Type
1.2.1 Global Antibody Drug Conjugate (ADC) Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type in 2019
1.2.3 Mmunomedics Technology
1.2.4 Immunogen Technology
1.2.5 Seattle Genetics Technology
1.2.6 Others
1.3 Global Antibody Drug Conjugate (ADC) Drug Market by Application
1.3.1 Overview: Global Antibody Drug Conjugate (ADC) Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biotechnology Companies
1.3.3 Specialized Cancer Centers
1.3.4 Biopharmaceutical Companies
1.3.5 Academic Research Institutes
1.3.6 Hospitals
1.3.7 Others
1.4 Global Antibody Drug Conjugate (ADC) Drug Market by Regions
1.4.1 Global Antibody Drug Conjugate (ADC) Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antibody Drug Conjugate (ADC) Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antibody Drug Conjugate (ADC) Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antibody Drug Conjugate (ADC) Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antibody Drug Conjugate (ADC) Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antibody Drug Conjugate (ADC) Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antibody Drug Conjugate (ADC) Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Oxford Bio Therapeutics
2.1.1 Oxford Bio Therapeutics Details
2.1.2 Oxford Bio Therapeutics Major Business
2.1.3 Oxford Bio Therapeutics SWOT Analysis
2.1.4 Oxford Bio Therapeutics Product and Services
2.1.5 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche Holding AG
2.2.1 Roche Holding AG Details
2.2.2 Roche Holding AG Major Business
2.2.3 Roche Holding AG SWOT Analysis
2.2.4 Roche Holding AG Product and Services
2.2.5 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer HealthCare
2.3.1 Bayer HealthCare Details
2.3.2 Bayer HealthCare Major Business
2.3.3 Bayer HealthCare SWOT Analysis
2.3.4 Bayer HealthCare Product and Services
2.3.5 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Synthon
2.4.1 Synthon Details
2.4.2 Synthon Major Business
2.4.3 Synthon SWOT Analysis
2.4.4 Synthon Product and Services
2.4.5 Synthon Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Concortis Bio therapeutics
2.5.1 Concortis Bio therapeutics Details
2.5.2 Concortis Bio therapeutics Major Business
2.5.3 Concortis Bio therapeutics SWOT Analysis
2.5.4 Concortis Bio therapeutics Product and Services
2.5.5 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Progenics Pharmaceuticals
2.6.1 Progenics Pharmaceuticals Details
2.6.2 Progenics Pharmaceuticals Major Business
2.6.3 Progenics Pharmaceuticals Product and Services
2.6.4 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Heidelberg Pharma
2.7.1 Heidelberg Pharma Details
2.7.2 Heidelberg Pharma Major Business
2.7.3 Heidelberg Pharma Product and Services
2.7.4 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Millennium Pharmaceuticals
2.9.1 Millennium Pharmaceuticals Details
2.9.2 Millennium Pharmaceuticals Major Business
2.9.3 Millennium Pharmaceuticals Product and Services
2.9.4 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Seattle Genetics
2.10.1 Seattle Genetics Details
2.10.2 Seattle Genetics Major Business
2.10.3 Seattle Genetics Product and Services
2.10.4 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Immunomedics
2.11.1 Immunomedics Details
2.11.2 Immunomedics Major Business
2.11.3 Immunomedics Product and Services
2.11.4 Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.12 ImmunoGen
2.12.1 ImmunoGen Details
2.12.2 ImmunoGen Major Business
2.12.3 ImmunoGen Product and Services
2.12.4 ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.13 Mersana Therapeutics
2.13.1 Mersana Therapeutics Details
2.13.2 Mersana Therapeutics Major Business
2.13.3 Mersana Therapeutics Product and Services
2.13.4 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.14 Genmab
2.14.1 Genmab Details
2.14.2 Genmab Major Business
2.14.3 Genmab Product and Services
2.14.4 Genmab Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.15 Agensys
2.15.1 Agensys Details
2.15.2 Agensys Major Business
2.15.3 Agensys Product and Services
2.15.4 Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.16 Celldex Therapeutics
2.16.1 Celldex Therapeutics Details
2.16.2 Celldex Therapeutics Major Business
2.16.3 Celldex Therapeutics Product and Services
2.16.4 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.17 Astellas Pharma/Agensys
2.17.1 Astellas Pharma/Agensys Details
2.17.2 Astellas Pharma/Agensys Major Business
2.17.3 Astellas Pharma/Agensys Product and Services
2.17.4 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.18 Sanofi
2.18.1 Sanofi Details
2.18.2 Sanofi Major Business
2.18.3 Sanofi Product and Services
2.18.3 Sanofi Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.19 Genentech
2.19.1 Genentech Details
2.19.2 Genentech Major Business
2.19.3 Genentech Product and Services
2.19.4 Genentech Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.20 AbbVie Inc
2.20.1 AbbVie Inc Details
2.20.2 AbbVie Inc Major Business
2.20.3 AbbVie Inc Product and Services
2.20.4 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.21 Amgen
2.21.1 Amgen Details
2.21.2 Amgen Major Business
2.21.3 Amgen Product and Services
2.21.4 Amgen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.22 Novartis
2.22.1 Novartis Details
2.22.2 Novartis Major Business
2.22.3 Novartis Product and Services
2.22.4 Novartis Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.23 Eli Lilly
2.23.1 Eli Lilly Details
2.23.2 Eli Lilly Major Business
2.23.3 Eli Lilly Product and Services
2.23.4 Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antibody Drug Conjugate (ADC) Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antibody Drug Conjugate (ADC) Drug Players Market Share
3.2.2 Top 10 Antibody Drug Conjugate (ADC) Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antibody Drug Conjugate (ADC) Drug Revenue and Market Share by Regions
4.2 North America Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
4.5 South America Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
5 North America Antibody Drug Conjugate (ADC) Drug Revenue by Countries
5.1 North America Antibody Drug Conjugate (ADC) Drug Revenue by Countries (2015-2020)
5.2 USA Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
6 Europe Antibody Drug Conjugate (ADC) Drug Revenue by Countries
6.1 Europe Antibody Drug Conjugate (ADC) Drug Revenue by Countries (2015-2020)
6.2 Germany Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
6.3 UK Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
6.4 France Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Countries
7.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Countries (2015-2020)
7.2 China Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
7.5 India Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
8 South America Antibody Drug Conjugate (ADC) Drug Revenue by Countries
8.1 South America Antibody Drug Conjugate (ADC) Drug Revenue by Countries (2015-2020)
8.2 Brazil Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antibody Drug Conjugate (ADC) Drug by Countries
9.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antibody Drug Conjugate (ADC) Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Antibody Drug Conjugate (ADC) Drug Market Forecast by Type (2019-2024)
10.3 Mmunomedics Technology Revenue Growth Rate (2015-2025)
10.4 Immunogen Technology Revenue Growth Rate (2015-2025)
10.5 Seattle Genetics Technology Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Antibody Drug Conjugate (ADC) Drug Market Segment by Application
11.1 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Application (2015-2020)
11.2 Antibody Drug Conjugate (ADC) Drug Market Forecast by Application (2019-2024)
11.3 Biotechnology Companies Revenue Growth (2015-2020)
11.4 Specialized Cancer Centers Revenue Growth (2015-2020)
11.5 Biopharmaceutical Companies Revenue Growth (2015-2020)
11.6 Academic Research Institutes Revenue Growth (2015-2020)
11.7 Hospitals Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast (2021-2025)
12.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast (2021-2025)
12.2 Global Antibody Drug Conjugate (ADC) Drug Market Forecast by Regions (2021-2025)
12.3 North America Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
12.4 Europe Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
12.6 South America Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibody Drug Conjugate (ADC) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Oxford Bio Therapeutics Corporate Information, Location and Competitors
Table 7. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Major Business
Table 8. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 9. Oxford Bio Therapeutics SWOT Analysis
Table 10. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 11. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Roche Holding AG Corporate Information, Location and Competitors
Table 13. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Major Business
Table 14. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2018-2019)
Table 15. Roche Holding AG SWOT Analysis
Table 16. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 17. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Bayer HealthCare Corporate Information, Location and Competitors
Table 19. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Major Business
Table 20. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 21. Bayer HealthCare SWOT Analysis
Table 22. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 23. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Synthon Corporate Information, Location and Competitors
Table 25. Synthon Antibody Drug Conjugate (ADC) Drug Major Business
Table 26. Synthon Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 27. Synthon SWOT Analysis
Table 28. Synthon Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 29. Synthon Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Concortis Bio therapeutics Corporate Information, Location and Competitors
Table 31. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Major Business
Table 32. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 33. Concortis Bio therapeutics SWOT Analysis
Table 34. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 35. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Progenics Pharmaceuticals Corporate Information, Location and Competitors
Table 37. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Major Business
Table 38. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 39. Progenics Pharmaceuticals SWOT Analysis
Table 40. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 41. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Heidelberg Pharma Corporate Information, Location and Competitors
Table 43. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Major Business
Table 44. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 45. Heidelberg Pharma SWOT Analysis
Table 46. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 47. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Pfizer Corporate Information, Location and Competitors
Table 49. Pfizer Antibody Drug Conjugate (ADC) Drug Major Business
Table 50. Pfizer Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 51. Pfizer SWOT Analysis
Table 52. Pfizer Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 53. Pfizer Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Millennium Pharmaceuticals Corporate Information, Location and Competitors
Table 55. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Major Business
Table 56. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 57. Millennium Pharmaceuticals SWOT Analysis
Table 58. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 59. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Seattle Genetics Corporate Information, Location and Competitors
Table 61. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Major Business
Table 62. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 63. Seattle Genetics SWOT Analysis
Table 64. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 65. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Immunomedics Corporate Information, Location and Competitors
Table 67. Immunomedics Antibody Drug Conjugate (ADC) Drug Major Business
Table 68. Immunomedics Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 69. Immunomedics SWOT Analysis
Table 70. Immunomedics Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 71. Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. ImmunoGen Corporate Information, Location and Competitors
Table 73. ImmunoGen Antibody Drug Conjugate (ADC) Drug Major Business
Table 74. ImmunoGen Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 75. ImmunoGen SWOT Analysis
Table 76. ImmunoGen Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 77. ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Mersana Therapeutics Corporate Information, Location and Competitors
Table 79. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Major Business
Table 80. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 81. Mersana Therapeutics SWOT Analysis
Table 82. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 83. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Genmab Corporate Information, Location and Competitors
Table 85. Genmab Antibody Drug Conjugate (ADC) Drug Major Business
Table 86. Genmab Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 87. Genmab SWOT Analysis
Table 88. Genmab Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 89. Genmab Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Agensys Corporate Information, Location and Competitors
Table 91. Agensys Antibody Drug Conjugate (ADC) Drug Major Business
Table 92. Agensys Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 93. Agensys SWOT Analysis
Table 94. Agensys Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 95. Agensys Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Celldex Therapeutics Corporate Information, Location and Competitors
Table 97. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Major Business
Table 98. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 99. Celldex Therapeutics SWOT Analysis
Table 100. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 101. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Astellas Pharma/Agensys Corporate Information, Location and Competitors
Table 103. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Major Business
Table 104. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 105. Astellas Pharma/Agensys SWOT Analysis
Table 106. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 107. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Sanofi Antibody Drug Conjugate (ADC) Drug Type and Application
Table 109. Sanofi Antibody Drug Conjugate (ADC) Drug Major Business
Table 110. Sanofi Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 111. Sanofi SWOT Analysis
Table 112. Sanofi Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 113. Sanofi Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Genentech Corporate Information, Location and Competitors
Table 115. Genentech Antibody Drug Conjugate (ADC) Drug Major Business
Table 116. Genentech Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 117. Genentech SWOT Analysis
Table 118. Genentech Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 119. Genentech Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. AbbVie Inc Corporate Information, Location and Competitors
Table 121. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Major Business
Table 122. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 123. AbbVie Inc SWOT Analysis
Table 124. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 125. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Amgen Corporate Information, Location and Competitors
Table 127. Amgen Antibody Drug Conjugate (ADC) Drug Major Business
Table 128. Amgen Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 129. Amgen SWOT Analysis
Table 130. Amgen Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 131. Amgen Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. Novartis Corporate Information, Location and Competitors
Table 133. Novartis Antibody Drug Conjugate (ADC) Drug Major Business
Table 134. Novartis Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 135. Novartis SWOT Analysis
Table 136. Novartis Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 137. Novartis Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 138. Eli Lilly Corporate Information, Location and Competitors
Table 139. Eli Lilly Antibody Drug Conjugate (ADC) Drug Major Business
Table 140. Eli Lilly Antibody Drug Conjugate (ADC) Drug Total Revenue (USD Million) (2017-2018)
Table 141. Eli Lilly SWOT Analysis
Table 142. Eli Lilly Antibody Drug Conjugate (ADC) Drug Product and Solutions
Table 143. Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 144. Global Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) by Players (2015-2020)
Table 145. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Players (2015-2020)
Table 146. Global Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) by Regions (2015-2020)
Table 147. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Regions (2015-2020)
Table 148. North America Antibody Drug Conjugate (ADC) Drug Revenue by Countries (2015-2020)
Table 149. North America Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries (2015-2020)
Table 150. Europe Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) by Countries (2015-2020)
Table 151. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) by Countries (2015-2020)
Table 152. South America Antibody Drug Conjugate (ADC) Drug Revenue by Countries (2015-2020)
Table 153. South America Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries (2015-2020)
Table 154. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) by Countries (2015-2020)
Table 155. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries (2015-2020)
Table 156. Global Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) by Type (2015-2020)
Table 157. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Type (2015-2020)
Table 158. Global Antibody Drug Conjugate (ADC) Drug Revenue Forecast by Type (2021-2025)
Table 159. Global Antibody Drug Conjugate (ADC) Drug Revenue by Application (2015-2020)
Table 160. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Application (2015-2020)
Table 161. Global Antibody Drug Conjugate (ADC) Drug Revenue Forecast by Application (2021-2025)
Table 162. Global Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Antibody Drug Conjugate (ADC) Drug Picture
Figure 2. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type in 2019
Figure 3. Mmunomedics Technology Picture
Figure 4. Immunogen Technology Picture
Figure 5. Seattle Genetics Technology Picture
Figure 6. Others Picture
Figure 7. Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Application in 2019
Figure 8. Biotechnology Companies Picture
Figure 9. Specialized Cancer Centers Picture
Figure 10. Biopharmaceutical Companies Picture
Figure 11. Academic Research Institutes Picture
Figure 12. Hospitals Picture
Figure 13. Others Picture
Figure 14. Global Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Antibody Drug Conjugate (ADC) Drug Revenue Market Share in 2019
Figure 23. Global Top 10 Players Antibody Drug Conjugate (ADC) Drug Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Regions (2015-2020)
Figure 27. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Regions in 2018
Figure 28. North America Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 29. Europe Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 31. South America Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 33. North America Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries (2015-2020)
Figure 34. North America Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries in 2019
Figure 35. USA Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 36. Canada Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 38. Europe Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries in 2019
Figure 40. Germany Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 41. UK Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 42. France Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 43. Russia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 44. Italy Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries in 2019
Figure 47. China Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 48. Japan Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 49. Korea Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 50. India Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 52. South America Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries (2015-2020)
Figure 53. South America Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries in 2019
Figure 54. Brazil Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 59. UAE Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2015-2020)
Figure 62. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Type (2015-2020)
Figure 63. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Type in 2019
Figure 64. Global Antibody Drug Conjugate (ADC) Drug Market Share Forecast by Type (2021-2025)
Figure 65. Global Mmunomedics Technology Revenue Growth Rate (2015-2020)
Figure 66. Global Immunogen Technology Revenue Growth Rate (2015-2020)
Figure 67. Global Seattle Genetics Technology Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Application (2015-2020)
Figure 70. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Application in 2019
Figure 71. Global Antibody Drug Conjugate (ADC) Drug Market Share Forecast by Application (2021-2025)
Figure 72. Global Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 73. Global Specialized Cancer Centers Revenue Growth Rate (2015-2020)
Figure 74. Global Biopharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 75. Global Academic Research Institutes Revenue Growth Rate (2015-2020)
Figure 76. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
Figure 82. Europe Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
Figure 84. South America Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
抗体薬物コンジュゲート治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Antibody Drug Conjugate Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…- 抗体薬物複合体（ADC）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Antibody Drug Conjugates (ADCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibody Drug…
- 次世代抗体治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Next Generation Antibody Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Next Ge…
- 血液脳関門薬物デリバリーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Drug Delivery Across Blood Brain Barrier market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 急性肝性ポルフィリン症治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Acute Hepatic Porphyria Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…